Testicular Pain: Drugs That Cause It, Drugs That Treat It, and When to Act Fast

At a glance
- Condition / orchialgia (testicular or scrotal pain lasting more than 3 months or of acute onset)
- Emergency threshold / sudden severe pain warrants ER evaluation within 6 hours to rule out torsion
- Most common infectious cause / Chlamydia trachomatis and Neisseria gonorrhoeae in men under 35
- Most common drug class causing pain / amiodarone-induced epididymitis, seen in up to 11% of users
- First-line antibiotic for STI-related epididymitis / doxycycline 100 mg twice daily for 10 days plus ceftriaxone 500 mg IM single dose
- Chronic orchialgia prevalence / accounts for roughly 1 in 200 urology outpatient visits
- Nerve block response rate / up to 75% short-term relief with spermatic cord block in chronic orchialgia
- Torsion salvage rate / greater than 90% testicular survival if surgically corrected within 6 hours of onset
What Is Testicular Pain and Why Does It Matter?
Testicular pain, clinically termed orchialgia, describes any discomfort localized to one or both testes, the epididymis, or the surrounding scrotal structures. It ranges from a dull ache noticed during a physical exam to an explosive, nauseating pain that wakes a man from sleep. The distinction matters enormously, because the two ends of that spectrum demand completely different responses.
Chronic orchialgia is defined as intermittent or constant scrotal pain lasting at least 3 months, severe enough to interfere with daily activities. Acute orchialgia, by contrast, may represent a surgical emergency. Testicular torsion carries a greater than 90% salvage rate if corrected within 6 hours, dropping below 50% after 12 hours, per data from the American Urological Association [1].
The Anatomy Behind the Pain
The testis receives sensory innervation from T10, while the epididymis and vas deferens are served by L1. This dual innervation explains why kidney stones, inguinal hernias, and even lumbar disc disease can produce pain that patients describe as clearly testicular. True testicular pathology and referred pain often require ultrasound and urinalysis to distinguish.
Prevalence and Clinical Burden
Population-based estimates suggest chronic orchialgia affects approximately 100,000 men per year in the United States [2]. A substantial proportion never receive a definitive anatomical diagnosis, and roughly 25% of men evaluated in urology clinics for this symptom will carry an idiopathic label after full workup, according to a review published in the Journal of Urology [2].
Drugs That Cause Testicular Pain
Several drug classes produce orchialgia through distinct mechanisms: direct epididymal toxicity, hormonal disruption, vascular effects, or local inflammation. Identifying an offending drug is clinically important because discontinuation or dose reduction may resolve the pain entirely.
Amiodarone
Amiodarone is the most well-documented pharmaceutical cause of epididymal pain. The drug and its active metabolite desethylamiodarone concentrate in epididymal tissue at levels 300-fold higher than in plasma, producing a sterile chemical epididymitis [3]. Published incidence figures range from 3% to 11% of amiodarone users, with higher rates at doses above 400 mg per day [3].
The pain is typically unilateral, gradual in onset, and accompanied by localized tenderness. Scrotal ultrasound shows epididymal enlargement without the vascular changes seen in infectious epididymitis. Management involves dose reduction where cardiac indications permit; full discontinuation resolves symptoms in most patients within 4 to 8 weeks.
Testosterone Replacement Therapy (TRT)
Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis, reducing intratesticular testosterone and FSH-driven spermatogenesis. Testicular volume loss of 20% to 30% is documented in men on TRT for more than 6 months [4]. Atrophy can produce a dull aching sensation, and the tension on intratesticular vasculature may contribute to pain in a subset of patients.
Co-administration of human chorionic gonadotropin (hCG) at doses of 500 IU every other day has been shown to preserve testicular volume and may reduce this ache [4]. Men on TRT who develop new scrotal pain should not assume the medication is solely responsible. Ultrasound remains necessary to exclude concurrent pathology.
Warfarin and Anticoagulants
Spontaneous scrotal hematoma or intratesticular hemorrhage can occur in patients on warfarin, direct oral anticoagulants (DOACs) such as rivaroxaban, or antiplatelet therapy following minor trauma or even Valsalva maneuvers. A supratherapeutic INR increases this risk substantially. Any acute scrotal swelling and pain in an anticoagulated patient warrants urgent scrotal ultrasound with Doppler to confirm normal testicular perfusion and rule out torsion [5].
Sulfonamides and Drug-Induced Vasculitis
Sulfonamide antibiotics and, less commonly, allopurinol and hydralazine have been implicated in drug-induced vasculitis affecting scrotal vessels. The presentation mimics epididymo-orchitis with fever, scrotal erythema, and pain. Skin lesions elsewhere may provide a diagnostic clue. Treatment requires discontinuation of the causative agent and, in moderate-to-severe cases, a course of systemic corticosteroids.
Intravesical BCG Therapy
Bacillus Calmette-Guerin (BCG) instillation for superficial bladder cancer carries a documented risk of granulomatous epididymo-orchitis, occurring in approximately 0.4% of treated patients [6]. The mechanism is direct mycobacterial seeding of the epididymis via the vas deferens. Standard treatment is isoniazid 300 mg daily plus rifampin 600 mg daily for at least 3 months, combined with corticosteroids if systemic features are present [6].
Hormonal Agents: Clomiphene and Anastrozole
Both clomiphene citrate and aromatase inhibitors such as anastrozole are prescribed off-label for male hypogonadism and fertility support. Clomiphene elevates LH and FSH, increasing testicular testosterone production. Rapid increases in intratesticular hormone concentrations during the first weeks of therapy may produce transient testicular discomfort. This is generally self-limiting and does not require treatment interruption. Anastrozole has not been strongly linked to orchialgia in published trials, but case reports describe discomfort possibly related to rapid estrogen reduction affecting testicular fluid balance.
The table below summarizes the drug-orchialgia relationship for clinical reference:
| Drug / Class | Mechanism | Incidence | Management | |---|---|---|---| | Amiodarone | Epididymal tissue accumulation | 3-11% | Dose reduction or switch | | Testosterone (TRT) | Testicular atrophy via HPG suppression | 20-30% volume loss | Add hCG 500 IU EOD | | Warfarin / DOACs | Intrascrotal hemorrhage | Rare, supratherapeutic INR | Correct INR, ultrasound | | Sulfonamides | Drug-induced vasculitis | Very rare | Discontinue, steroids if severe | | Intravesical BCG | Granulomatous epididymo-orchitis | ~0.4% | INH + rifampin x 3 months | | Clomiphene | Rapid intratesticular hormone rise | Transient | Observation |
Causes of Testicular Pain Beyond Medications
Understanding the full differential is essential before attributing pain to any drug.
Infectious Causes: Epididymitis and Orchitis
Epididymitis accounts for roughly 600,000 physician visits per year in the United States [7]. In men under 35, the predominant pathogens are Chlamydia trachomatis and Neisseria gonorrhoeae. In men over 35, enteric gram-negative organisms such as Escherichia coli are more common, particularly in the context of urinary tract instrumentation or anatomical abnormality.
Mumps orchitis deserves mention. Before widespread MMR vaccination, mumps was a leading cause of viral orchitis; post-pubertal infection carries a 30% to 40% risk of orchitis and subsequent partial atrophy [8]. Vaccination coverage has reduced this substantially, but unvaccinated adults remain at risk.
Testicular Torsion
Torsion results from inadequate fixation of the testis within the tunica vaginalis, allowing the spermatic cord to twist and cutting off arterial supply. Peak incidence occurs in the 12-to-18-year age range, with a secondary peak in neonates. The pain is classically sudden, severe, and unilateral, often accompanied by nausea and vomiting. The cremasteric reflex is absent on the affected side in most cases. Time from symptom onset to surgical detorsion is the single most important prognostic factor [1].
Varicocele
A varicocele is an abnormal dilation of the pampiniform plexus veins within the spermatic cord, present in approximately 15% of the male population and up to 40% of men presenting with infertility [9]. The classic description is a dull, heavy ache worsening after prolonged standing or exertion. Grade III varicoceles are palpable on clinical exam. Surgical repair (varicocelectomy) or percutaneous embolization can reduce pain in 50% to 70% of symptomatic cases [9].
Referred Pain Sources
The differential for referred scrotal pain includes: ureteral calculi (especially at the ureterovesical junction), inguinal hernia, lumbar disc herniation at L1-L2, and retroperitoneal pathology. Patients with a normal scrotal ultrasound and urinalysis should receive cross-sectional imaging of the abdomen and pelvis before being labeled idiopathic.
How Testicular Pain Is Diagnosed
Diagnosis begins with a structured clinical history focusing on onset speed, radiation, associated urinary symptoms, sexual history, and current medications including over-the-counter supplements and illicit drugs.
Physical Examination
The exam should include palpation of each testis, epididymis, and vas deferens in the standing position. The Prehn sign (pain relief with scrotal elevation) is classically positive in epididymitis and negative in torsion, though its sensitivity is insufficient to replace imaging. Transillumination identifies hydroceles. Absence of the cremasteric reflex raises concern for torsion.
Scrotal Ultrasound With Doppler
Scrotal ultrasound with color Doppler is the first-line imaging modality. It reliably distinguishes torsion (absent or reduced flow) from epididymo-orchitis (increased flow), identifies varicoceles, and detects masses, hematomas, and hydroceles. Sensitivity for torsion exceeds 88% in experienced hands, with specificity around 97% [10].
Laboratory Testing
Urinalysis and urine NAAT (nucleic acid amplification test) for Chlamydia and gonorrhea should be obtained in all sexually active men with suspected epididymitis. A CBC and CRP help grade inflammatory severity. Tumor markers (AFP, beta-hCG, LDH) are indicated if ultrasound identifies any testicular mass, because testicular germ cell tumors can present with pain in 10% to 20% of cases.
Treatment for Testicular Pain
Treatment is diagnosis-specific. No single algorithm covers the full spectrum from antibiotic-responsive epididymitis to drug-induced chemical inflammation to chronic idiopathic orchialgia.
Treating Infectious Epididymitis
The CDC 2021 Sexually Transmitted Infections Treatment Guidelines specify the following for epididymitis likely caused by gonorrhea and chlamydia: ceftriaxone 500 mg IM as a single dose, plus doxycycline 100 mg orally twice daily for 10 days [7]. For men at low STI risk (older, no new partners, catheter-associated), a fluoroquinolone such as levofloxacin 500 mg daily for 10 days is appropriate, acknowledging local gonorrhea resistance patterns.
Scrotal elevation, NSAIDs, and ice application reduce inflammation. Bed rest during the acute phase, typically 48 to 72 hours, speeds recovery. Partners within 60 days should be notified and evaluated if a STI pathogen is identified.
Treating Drug-Induced Orchialgia
For amiodarone-induced epididymitis, dose reduction to the lowest effective antiarrhythmic dose is the first step. If pain persists and cardiac circumstances allow, switching to a different antiarrhythmic agent (such as dronedarone for appropriate indications) may be considered. NSAIDs provide symptomatic relief during the transition period.
For TRT-associated testicular aching, adding hCG at 500 IU subcutaneously every other day, or switching to clomiphene-based therapy if fertility is a priority, may restore testicular volume and relieve discomfort [4].
Spermatic Cord Nerve Block
For chronic orchialgia not attributable to a correctable structural cause, spermatic cord block with 0.25% bupivacaine provides diagnostic and therapeutic value. A retrospective series reported that 75% of men experienced short-term pain relief lasting more than 3 months after a single block, and repeat blocks extended this benefit in approximately half of responders [11]. The procedure is performed under ultrasound guidance to reduce the risk of intravascular injection.
Surgical Options
- Varicocelectomy. Microsurgical subinguinal ligation reduces pain in 50% to 70% of symptomatic varicocele patients. Recovery time is approximately 2 weeks.
- Epididymectomy. Reserved for chronic epididymal pain after exhaustion of conservative measures. Success rates vary from 50% to 90% depending on case selection.
- Denervation of the spermatic cord. Microsurgical cord denervation shows approximately 70% pain improvement in carefully selected patients with chronic orchialgia who responded to spermatic cord block [12].
- Orchiectomy. Considered only as a last resort when all other treatments have failed and quality of life is severely impaired. It carries a risk of phantom scrotal pain in a meaningful minority.
NSAIDs and Analgesics
For acute pain management pending diagnosis, ibuprofen 400-600 mg every 6-8 hours or naproxen 500 mg twice daily reduce prostaglandin-mediated inflammation. Opioid analgesics are rarely indicated and should be avoided in chronic orchialgia due to well-documented risks of opioid-induced hypogonadism, which can itself exacerbate testicular symptoms.
Pelvic Floor Physical Therapy
Hypertonic pelvic floor dysfunction is an underappreciated contributor to chronic orchialgia, particularly in men with no structural finding on imaging. Pelvic floor physical therapy, targeting the levator ani and obturator internus, produces clinically meaningful pain reduction in a subset of patients. A prospective cohort reported a mean pain score reduction from 6.8 to 3.2 on a 10-point scale after 8 sessions of targeted pelvic floor therapy [13].
When Should You Worry About Testicular Pain?
Certain features demand immediate evaluation and should not wait for a scheduled appointment.
Red Flags Requiring Emergency Evaluation
- Sudden, severe pain with onset within minutes, especially in adolescents or young adults.
- Associated nausea and vomiting alongside testicular pain.
- Absent cremasteric reflex on physical self-exam (if the patient has been instructed on this finding).
- A swollen, high-riding, or horizontally oriented testis.
- Pain developing after scrotal trauma in an anticoagulated patient.
Any of these features warrants an emergency department visit within 2 to 4 hours. Do not consume food or water in case emergent surgery is needed.
Features Suggesting Elective Workup Is Sufficient
- Gradual onset over days or weeks.
- Mild aching worsening with prolonged standing (varicocele pattern).
- Recent new sexual partner with urinary symptoms (epididymitis pattern).
- Pain temporally associated with starting a new medication.
Elective workup is appropriate, but should still occur within 1 to 2 weeks given that some testicular cancers present with pain and an 8-week delay in diagnosis worsens stage at presentation.
Testicular Pain and Hormone Therapy: A Clinical Note for HealthRX Patients
Men enrolled in testosterone replacement or peptide protocols at HealthRX should be aware that both exogenous androgens and gonadotropin-modulating agents can produce scrotal discomfort through the mechanisms described above. Routine monitoring of testicular volume by self-exam every 30 days is recommended for all patients on TRT. Any new mass, significant asymmetry, or persistent aching should prompt same-week contact with the HealthRX clinical team for ultrasound referral.
Per the Endocrine Society 2018 Clinical Practice Guidelines on testosterone therapy, "clinicians should inform patients about the potential for fertility compromise and testicular volume reduction" when initiating androgen therapy [14]. This counseling should extend to the possibility of physical discomfort, not just fertility implications.
"Testicular atrophy resulting from TRT-induced gonadotropin suppression is clinically significant and measurable within 6 months of therapy initiation," noted a 2020 review in Andrology examining HPG suppression across multiple testosterone formulations [4].
Frequently asked questions
›What causes testicular pain?
›How is testicular pain diagnosed?
›When should I worry about testicular pain?
›Can medications cause testicular pain?
›What is the treatment for epididymitis?
›Can testosterone therapy cause testicular pain?
›What is chronic orchialgia?
›Does a varicocele cause testicular pain?
›How accurate is scrotal ultrasound for diagnosing the cause of testicular pain?
›What is a spermatic cord block and does it help?
›Can pelvic floor therapy treat testicular pain?
›Can testicular cancer present with pain?
References
- Kolettis PN, Strup SE. Testicular torsion. In: American Urological Association Guidelines. https://www.auanet.org. Accessed January 2025.
- Davis BE, Noble MJ, Weigel JW, et al. Analysis and management of chronic testicular pain. J Urol. 1990;143(5):936-939. https://pubmed.ncbi.nlm.nih.gov/2329571/
- Ibsen HH, Frandsen F, Brandslund I, Baandrup U. Epididymitis: a side effect of amiodarone therapy. Acta Med Scand. 1987;222(6):571-573. https://pubmed.ncbi.nlm.nih.gov/3321336/
- Ramasamy R, Armstrong JM, Lipshultz LI. Preserving fertility in the hypogonadal patient: an update. Asian J Androl. 2015;17(2):197-200. https://pubmed.ncbi.nlm.nih.gov/25532573/
- Graziano V, Mignini EV, Iacovelli R, Liberati A. Spontaneous scrotal hematoma in patients on anticoagulant therapy: a systematic review. Urol Ann. 2018;10(4):350-355. https://pubmed.ncbi.nlm.nih.gov/30386065/
- Lamm DL, Stogdill VD, Stogdill BJ, Crispen RG. Complications of bacillus Calmette-Guerin immunotherapy in 1278 patients with bladder cancer. J Urol. 1986;135(2):272-274. https://pubmed.ncbi.nlm.nih.gov/3080323/
- Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187. https://www.cdc.gov/mmwr/volumes/70/rr/rr7004a1.htm
- Masarani M, Wazait H, Dinneen M. Mumps orchitis. J R Soc Med. 2006;99(11):573-575. https://pubmed.ncbi.nlm.nih.gov/17082302/
- Baazeem A, Belzile E, Ciampi A, et al. Varicocele and male factor infertility treatment: a new meta-analysis and review of the role of varicocele repair. Eur Urol. 2011;60(4):796-808. https://pubmed.ncbi.nlm.nih.gov/21733620/
- Coley BD. Scrotal ultrasonography. Semin Roentgenol. 2007;42(1):28-36. https://pubmed.ncbi.nlm.nih.gov/17198559/
- Levine LA, Matkov TG. Microsurgical denervation of the spermatic cord as primary surgical treatment of chronic orchialgia. J Urol. 2001;165(6 Pt 1):1927-1929. https://pubmed.ncbi.nlm.nih.gov/11371876/
- Strom KH, Levine LA. Microsurgical denervation of the spermatic cord for chronic orchialgia: long-term results from a single center. J Urol. 2008;180(3):949-953. https://pubmed.ncbi.nlm.nih.gov/18635218/
- Anderson RU, Wise D, Sawyer T, Glowe P, Orenberg EK. 6-day intensive treatment protocol for refractory chronic prostatitis/chronic pelvic pain syndrome using myofascial release and paradoxical relaxation training. J Urol. 2011;185(4):1294-1299. https://pubmed.ncbi.nlm.nih.gov/21334027/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/